Company intelligence / Profile preview

Ennocure MedTech

Maor, Israel

Ownership: Private
Development stage: Other

Overview

Ennocure's proprietary bio-electronic treatment, in collaboration with Inspira, demonstrated 100% prevention of bacterial growth causing bloodstream infections in ICU patients during in vitro studies; their smart patch for wound healing is under development with no published human clinical results yet.

Therapeutic areas: Infectious DiseasesDermatology
Modalities: DeviceBio-electronic wound dressing
Industry: Therapeutic Medical Devices

Partnerships

Inspira Technologies

Beyond the preview

Go deeper on Ennocure MedTech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ennocure MedTech.

Explore the full profile